Literature DB >> 2414277

Differing reactions of monoclonal anti-A antibodies with oligosaccharides related to blood group A.

H C Gooi, E F Hounsell, J K Picard, A D Lowe, D Voak, E S Lennox, T Feizi.   

Abstract

Inhibition radioimmunoassays with blood group A-related oligosaccharides have been used to investigate the specificities of six monoclonal anti-A antibodies, three of which had been intentionally generated by immunization of mice with blood group A erythrocytes and A-active blood group substance, and three were incidentally produced following immunization of mice with human tonsil cell membranes or a human colon cancer cell line. By hemagglutination, these antibodies are highly specific for human blood group A erythrocytes. However, they differ from one another in their reaction patterns with mono- and difucosyl A antigen structures and the corresponding afucosyl sequences on Type 1 and Type 2 backbone structures. The six antibodies, together with four previously characterized anti-A monoclonal antibodies (originally raised against the receptor for epidermal growth factor) have been classified into five groups. The first two groups consist of antibodies with broad specificities for A-related structures. There are five antibodies in the first group (TL5, 29.1, A17/3D1, MH2/6D4, and MH1/5D1) reacting to varying degrees with the mono- and difucosyl A antigen structures on either type of backbone sequence. In the second group are two antibodies (A15/3D4 and A15/3D3) which are difficult to inhibit with the oligosaccharides tested, but they reacted best with monofucosyl A structure on either type of backbone. Each of the remaining three antibodies had a distinct and more restricted reaction pattern, with a specificity for the difucosyl A antigen on both types of backbone (antibody EGR/G49) or the Type 1-based mono- and difucosyl A antigen structures (antibody MAS 016c) or the Type 2-based monofucosyl A antigen structure (antibody 455). The reactions of four of the antibodies with N-acetylgalactosamine or with oligosaccharides containing the afucosyl sequence GalNAc alpha 1-3Gal suggest that they may react with certain glycoconjugates with alpha-N-acetylgalactosaminyl termini ("A-like" structures) that are unrelated to the products of the blood group A gene-specified alpha-N-acetylgalactosaminyl-transferase. Knowledge of the differing reactions of these monoclonal antibodies is important for interpreting their reactions with glycoproteins and glycolipids of diverse origins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414277

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Difference in the ability of blood group-specific lectins and monoclonal antibodies to recognize the ABH antigens in human tissues.

Authors:  N Ito; K Nishi; S Kawahara; Y Okamura; T Hirota; S Rand; G Fechner; B Brinkmann
Journal:  Histochem J       Date:  1990-11

2.  Heterogeneity of the blood group ABH antigens and variation in the expression of these antigens of secretory granules in human cervical glands. An electron microscopic observation using lectins and monoclonal antibodies.

Authors:  Y Okamura
Journal:  Histochemistry       Date:  1990

3.  Diverse molecular recognition properties of blood group A binding monoclonal antibodies.

Authors:  Jeffrey C Gildersleeve; Whitney Shea Wright
Journal:  Glycobiology       Date:  2016-01-10       Impact factor: 4.313

4.  Model-building study of the combining sites of two antibodies to alpha (1----6)dextran.

Authors:  E A Padlan; E A Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Relationship of epidermal growth factor receptor detectability with the A, B, H blood group antigens. Emphasis on normal and neoplastic urothelium.

Authors:  C Limas
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

6.  Improved procedure for the construction of neoglycolipids having antigenic and lectin-binding activities, from reducing oligosaccharides.

Authors:  M S Stoll; T Mizuochi; R A Childs; T Feizi
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

7.  Inhibition of proliferation of normal and transformed neural cells by blood group-related oligosaccharides.

Authors:  F F Santos-Benito; A Fernández-Mayoralas; M Martín-Lomas; M Nieto-Sampedro
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.